Stock listing

gettex:6JU0 BioCardia, Inc. Aktie

German listing (gettex) of BioCardia, Inc. · home listing NASDAQ:BCDA

Follow BioCardia, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:BCDA

$0.92 USD -0.02 (-2.0%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:BCDA

Since Jul 6, 2026 -21.4% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$0.91 – $0.961 USDOct 16, 2026
Volume
104,788 sharesOct 16, 2026
Market value
$13.93M USDAt the close on Oct 16, 2026 · price × 15.14M shares outstanding
BioCardia, Inc. logo
Ticker
gettex:6JU0
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
gettex
Currency
EUR

What changed lately

Calls

Replays

  • Biocardia (NASDAQ:BCDA) Q2 2026 Earnings Call

    Wed, Aug 12, 2026 · 4:30 PM ET

    Watch Transcript

  • Biocardia (NASDAQ:BCDA) Q1 2026 Earnings Call

    Fri, May 15, 2026 · 4:30 PM ET

    Watch Transcript

  • Biocardia (NASDAQ:BCDA) Q4 2025 Earnings Call

    Tue, Mar 24, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting

Oct 7, 2026

BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter

Oct 1, 2026

BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission

Sep 23, 2026

BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference

Sep 10, 2026

BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-On De Novo Pre-Submission for Approval

Aug 24, 2026

BioCardia Reports Second Quarter 2026 Business Highlights and Financial Results

Aug 12, 2026

BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026

Aug 5, 2026

BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities

Jun 18, 2026

BioCardia Announces $4.4 Million Financing

Jun 8, 2026

BioCardia Announces Japan PMDA Record Of Advice Supports Regulatory Submission For Approval Of CardiAMP Cell Therapy For Ischemic Heart Failure

May 28, 2026

All BioCardia, Inc. news

Decks

BioCardia, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
32 in the last 12 months · 181 in all · newest Oct 7, 2026 · oldest 2019
Calls
19 calls with a replay · 19 with a transcript · latest Aug 12, 2026
Decks
11 decks · latest August 2026

Where BioCardia, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BCDA · Home listingNASDAQUnited StatesUSD
BOATS:BCDABOATSUnited StatesUSD
Frankfurt:6JU0FrankfurtGermanyEUR
gettex:6JU0 · This pagegettexGermanyEUR
Lang & Schwarz:A40D1SLang & SchwarzGermanyEUR

Log in to ask 6ix AI your own questions about BioCardia, Inc.